DDW update by Dr. Maheshwari 2016
i. EUS based Hepatic vein portal gradient – first humanized trial done with success. Use – for example Renal transplant patient with cirrhosis. Poor outcome if gradient more than 12
ii. Doppler Endoscopic probe : Used to assess efficacy of variceal bleed banding
iii. C diff : Overall cure rate with FMT is 82%, cure rate for recurrent CDI with colonoscopy was 87% compared to UGI instillation was 69%. Data from Openbiome, Meford Ma
iv. Recurrent CDI was not higher if patients were on PPI / acid suppression
v. Metaanalysis showed robust efficacy of prevention of CDI with use of probiotics. Strains and dose not yet clear.